Search

Displaying results 8281 - 8290 of 10000 in total
  1. Drug

    Pidilizumab

    go.drugbank.com/drugs/DB15383
    Investigational

    Pidilizumab is under investigation in clinical trial NCT01952769 (Anti PD1 Antibody in Diffuse Intrinsic Pontine Glioma).

  2. Drug

    SB-773812

    go.drugbank.com/drugs/DB16042
    Investigational

    SB-773812 is under investigation in clinical trial NCT00259870 (SB-773812 Administered in Adults With Schizophrenia).

  3. Drug

    Amcasertib

    go.drugbank.com/drugs/DB14866
    Investigational

    Amcasertib is under investigation in clinical trial NCT02483247 (A Study of BBI503 in Combination With Selected Anti-Cancer Therapeutics in Adult Patients With Advanced Cancer).

  4. Drug

    APG-1387

    go.drugbank.com/drugs/DB16095
    Investigational

    APG-1387 is under investigation in clinical trial NCT04568265 (A Clinical Study of APG-1387 in Combination With Entecavir in Patients With Chronic Hepatitis B).

  5. Drug

    L-deprenyl-D2 C-11

    go.drugbank.com/drugs/DB12650
    Experimental

    L-deprenyl-D2 C-11 is under investigation in clinical trial NCT01701089 (A Study of RO4602522 in Patients With Alzheimer Disease and in Healthy Volunteers).

  6. Drug

    MORF-057

    go.drugbank.com/drugs/DB23674
    Investigational

    MORF-057 is a small molecule drug. MORF-057 is under investigation in clinical trial NCT06226883 (A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease).

  7. Drug

    Human growth hormone-releasing peptide 3

    go.drugbank.com/drugs/DB19227
    Investigational

    Human growth hormone-releasing peptide 3 is under investigation in clinical trial NCT00846872 (Effect of Continuous GHRP-3 Infusion at on GH-IGF-I System, Blood Pressure, Glucose, and Insulin Resistance

  8. Drug

    Whey

    go.drugbank.com/drugs/DB18685
    Experimental

    Whey allergenic extract is used in allergenic testing.

  9. Drug

    PF-04620110

    go.drugbank.com/drugs/DB14887
    Investigational

    PF-04620110 is under investigation in clinical trial NCT01146327 (A Multiple Dose Study Of PF-04620110 In Healthy Overweight Or Obese Subjects).

  10. Drug

    Spartalizumab

    go.drugbank.com/drugs/DB14892
    Investigational

    Spartalizumab is under investigation in clinical trial NCT02605967 (Safety and Efficacy Study of PDR001 in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma).